Jiangsu Jibeier Pharmaceutical Co Ltd
Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China. The company's products cover multiple therapeutic areas such as increasing white blood cells, fighting hypertension, enhancing immunity, treating joint diseases, fighting eye infections, treating bronchitis, protecting liver function, etc. It is also developing… Read more
Jiangsu Jibeier Pharmaceutical Co Ltd (688566) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.005x
Based on the latest financial reports, Jiangsu Jibeier Pharmaceutical Co Ltd (688566) has a cash flow conversion efficiency ratio of 0.005x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥11.07 Million) by net assets (CN¥2.37 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jiangsu Jibeier Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Jiangsu Jibeier Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Jiangsu Jibeier Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangsu Jibeier Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DREAM UNLIMITED A SV
F:50DA
|
N/A |
|
Zhejiang Zhengyuan Zhihui Technology Co Ltd
SHE:300645
|
0.057x |
|
Rezolve AI PLC
F:O5F
|
N/A |
|
Lyell Immunopharma Inc
NASDAQ:LYEL
|
-0.087x |
|
Renxin New Material Co. Ltd. A
SHE:301395
|
N/A |
|
HEBA Fastighets AB (publ)
ST:HEBA-B
|
0.002x |
|
BRAZIL RES
F:BSR
|
-0.043x |
|
Jiangxi JDL Environmental Protection Co. Ltd. A
SHG:688057
|
0.015x |
Annual Cash Flow Conversion Efficiency for Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Jiangsu Jibeier Pharmaceutical Co Ltd from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.25 Billion | CN¥215.29 Million | 0.096x | +14.41% |
| 2023-12-31 | CN¥1.91 Billion | CN¥159.50 Million | 0.083x | -6.15% |
| 2022-12-31 | CN¥1.69 Billion | CN¥150.72 Million | 0.089x | -4.97% |
| 2021-12-31 | CN¥1.61 Billion | CN¥150.56 Million | 0.094x | +25.73% |
| 2020-12-31 | CN¥1.58 Billion | CN¥117.36 Million | 0.074x | -69.66% |
| 2019-12-31 | CN¥470.46 Million | CN¥115.45 Million | 0.245x | -10.41% |
| 2018-12-31 | CN¥357.68 Million | CN¥97.97 Million | 0.274x | +8.12% |
| 2017-12-31 | CN¥440.76 Million | CN¥111.66 Million | 0.253x | +134.16% |
| 2016-12-31 | CN¥363.15 Million | CN¥39.29 Million | 0.108x | -- |